Drug · DIN 02312263
CESAMET
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 27, 2019; first marketed September 12, 2008.
- Drug Identification Number (DIN)
- 02312263
- Company (DIN owner)
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Schedule
- Narcotics (CDSA II)
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Nabilone A04AD11
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NABILONE | 0.25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 27, 2019: NOC 22200New Drug Submission (NDS) · Administrative: Change in Product Ownership
- June 4, 2008: NOC 9585Supplement to a New Drug Submission (SNDS) · New strength: 0.25 mg.
Other DINs named CESAMET
- DIN 00548375 · Marketed
- DIN 02256193 · Marketed